Trend analysis: Biodiversity, conservation genetics & restoration — where the value pools are (and who captures them)

The global biodiversity economy is no longer a philanthropic afterthought. In 2025, the combined market for biodiversity credits, conservation genetics services, and ecosystem restoration reached an estimated $12.4 billion, growing at 28% annually since 2022, according to the Paulson Institute's Financing Nature report. Yet the distribution of value within this rapidly expanding sector is strikingly uneven: roughly 65% of economic returns concentrate in three subsegments that together represent less than 30% of total activity. For executives evaluating capital allocation, understanding where the value pools actually sit, and which players are positioned to capture them, is the difference between strategic positioning and expensive greenwashing.

Why It Matters

The Kunming-Montreal Global Biodiversity Framework, adopted in December 2022, committed 196 nations to protecting 30% of land and ocean by 2030 and mobilizing $200 billion annually for biodiversity conservation. By early 2026, more than 40 countries have submitted national biodiversity strategies and action plans, and the financing gap remains substantial. The Paulson Institute estimates that current biodiversity finance flows cover roughly $143 billion of the $700-$900 billion needed annually, leaving a shortfall that represents both a crisis and a market opportunity.

In the United States, the regulatory landscape has shifted decisively. The Inflation Reduction Act allocated $19.5 billion to agricultural conservation programs through the USDA, including provisions supporting genetic resource conservation and habitat restoration. The SEC's finalized climate disclosure rules, while focused on carbon, have prompted institutional investors to demand biodiversity risk assessments as part of due diligence. The Taskforce on Nature-related Financial Disclosures (TNFD) published its final recommendations in September 2023, and by 2025, more than 400 organizations globally had adopted the framework, with major US financial institutions including JPMorgan Chase, Bank of America, and Citigroup among early adopters.

Conservation genetics specifically has moved from academic curiosity to operational necessity. The cost of whole-genome sequencing dropped below $200 per sample in 2025, making population-level genetic assessments economically viable for the first time. Environmental DNA (eDNA) monitoring costs fell 60% between 2021 and 2025, enabling continuous biodiversity surveillance at landscape scale. These technology cost curves are creating entirely new service markets where none existed five years ago.

The economic logic is straightforward. Organizations that can reliably measure, verify, and monetize biodiversity outcomes will capture disproportionate value as regulatory mandates, voluntary commitments, and insurance requirements drive demand for credible biodiversity data and restoration services.

Key Concepts

Conservation Genetics applies genomic tools to manage and recover wild populations. Techniques include population viability analysis using microsatellite or SNP markers, landscape genetics mapping gene flow corridors, genetic rescue through managed translocation, and genomic selection for adaptive traits in restoration plantings. The field has expanded from endangered species management to routine application in commercial forestry, fisheries management, and agricultural biodiversity programs.

Environmental DNA (eDNA) refers to genetic material shed by organisms into their environment through skin cells, feces, mucus, and decomposition. Water or soil samples analyzed through metabarcoding can detect hundreds of species from a single collection, replacing labor-intensive traditional surveys. eDNA monitoring has become the fastest-growing segment of biodiversity assessment, with the global market projected to reach $1.8 billion by 2027 according to MarketsandMarkets.

Biodiversity Credits are tradeable units representing measurable, verified gains in biodiversity, analogous to carbon credits but measuring species richness, habitat quality, or ecosystem integrity. Unlike carbon markets, biodiversity credit standards remain fragmented, with multiple competing methodologies from Verra, Plan Vivo, and newer entrants including ValueNature and the Wallacea Trust.

Ecosystem Restoration encompasses interventions from revegetation and rewilding to engineered wetlands and coral reef rehabilitation. The UN Decade on Ecosystem Restoration (2021 to 2030) catalyzed over $27 billion in pledged restoration investments globally, though actual disbursement has lagged commitments by approximately 40%.

Biobanking and Genetic Repositories preserve genetic material from threatened species and ecosystems as insurance against extinction and as resources for future restoration. The value of biobanked genetic material appreciates as wild populations decline, creating a unique asset class with characteristics resembling intellectual property.

Where the Value Pools Concentrate

Biodiversity Measurement, Reporting, and Verification (MRV)

The single largest emerging value pool sits in biodiversity MRV, the infrastructure layer that enables all other market mechanisms. Organizations cannot trade what they cannot measure, and the measurement challenge for biodiversity dwarfs that of carbon. Whereas carbon accounting relies on relatively standardized emission factors and activity data, biodiversity assessment requires species identification, habitat quality scoring, functional ecosystem evaluation, and temporal monitoring across heterogeneous landscapes.

Companies providing scalable, technology-enabled biodiversity MRV are capturing margins of 40 to 60% on services that are becoming regulatory requirements. NatureMetrics, a UK-based eDNA analytics company, processed over 50,000 samples in 2025 and has expanded operations to the US through a partnership with the US Fish and Wildlife Service. Their platform converts water and soil samples into standardized biodiversity indices that meet TNFD reporting requirements.

Conservation Genetics Services

The second major value pool centers on applied conservation genetics. Revive & Restore, a nonprofit that has pioneered genetic rescue for species including the black-footed ferret, has catalyzed a commercial ecosystem around genetic tools for conservation. Colossal Biosciences, which raised $225 million through 2025 to pursue de-extinction projects for the woolly mammoth and the dodo, has spun off conservation genetics technologies applicable to existing endangered species recovery programs.

The US Fish and Wildlife Service now requires genetic assessments for all species recovery plans, creating a guaranteed demand floor for conservation genetics laboratories. The Smithsonian Conservation Biology Institute's Center for Conservation Genomics processes approximately 15,000 genetic samples annually, with a growing backlog suggesting demand significantly exceeds current laboratory capacity.

Commercial forestry represents an overlooked application. Weyerhaeuser and other major timber companies have invested in genomic selection programs that improve seedling survival rates by 15 to 25% while maintaining genetic diversity in replanted forests, generating returns through reduced replanting costs and faster growth rates.

Ecosystem Restoration at Scale

Large-scale restoration projects represent the third concentration of value, though margins are thinner and execution risk is higher. The Inflation Reduction Act's conservation provisions have created a pipeline of federally funded restoration projects exceeding $4 billion through 2027, primarily administered through USDA's Natural Resources Conservation Service and the US Forest Service.

Terrain, formerly known as TerraRestore, has emerged as the largest commercial restoration contractor in the US, managing over 200,000 acres of active restoration across 28 states. Their competitive advantage lies in proprietary seed mixes optimized through genetic testing for regional adaptation, combined with drone-based planting technology that reduces per-acre costs by 35 to 50% compared to manual methods.

DroneSeed, acquired by a major forestry company in 2024, demonstrated that aerial reforestation using drone swarms could plant 40 acres per day, roughly 100 times the rate of manual planting crews. The economics are compelling: drone reforestation costs $500 to $800 per acre compared to $1,200 to $2,500 for manual planting, with comparable survival rates when combined with genetically appropriate seed selection.

What's Working

The convergence of eDNA monitoring, genomic tools, and remote sensing has created integrated biodiversity intelligence platforms that were technically impossible five years ago. The Nature Conservancy's deployment of eDNA monitoring across 1,200 freshwater sites in the US has generated the largest standardized biodiversity dataset in history, enabling predictive models that guide restoration investments toward sites with the highest probability of success.

Biodiversity credit markets, while still nascent, are demonstrating proof of concept. Australia's biodiversity offset market, the most mature globally, transacted $890 million in 2024. In the US, mitigation banking for wetlands and endangered species habitat generated $3.2 billion in 2025, with the highest-performing banks achieving returns of 15 to 22% on invested capital according to the National Mitigation Banking Association.

Corporate demand for biodiversity data is accelerating faster than anticipated. A 2025 survey by CDP found that 1,800 companies reported on biodiversity impacts, up from 400 in 2022. Financial institutions managing over $19 trillion in assets have committed to TNFD-aligned reporting, creating downstream demand for biodiversity data from portfolio companies.

What's Not Working

Biodiversity credit standards remain fragmented and immature. Unlike carbon markets, which coalesced around a few dominant registries, biodiversity credits lack consensus on what constitutes a "unit" of biodiversity gain, how permanence should be defined, or what monitoring frequency is sufficient. This fragmentation depresses buyer confidence and limits market liquidity. The Biodiversity Credit Alliance, launched in 2024, has made progress on harmonization but has not yet produced binding standards.

Genetic rescue and assisted migration remain politically contentious. Despite strong scientific evidence supporting managed translocation of genetically depleted populations, regulatory frameworks in the US treat any movement of listed species as a potential violation of the Endangered Species Act. The US Fish and Wildlife Service has issued guidance supporting genetic rescue in specific cases, but project-by-project approval processes add 12 to 24 months and significant legal costs.

Restoration monitoring suffers from a credibility gap. A 2024 meta-analysis published in Nature Ecology & Evolution found that only 32% of restoration projects included monitoring beyond three years, and fewer than 15% used genetic diversity metrics to assess long-term population viability. Without rigorous monitoring, the distinction between genuine restoration and cosmetic revegetation remains difficult to verify at scale.

Key Players

Established Leaders

The Nature Conservancy operates the largest conservation program in the US, managing over 125 million acres globally and pioneering market-based conservation finance mechanisms including green bonds and biodiversity impact investments.

Conservation International has deployed over $2 billion in conservation finance since 2020 and manages biodiversity credit programs across 30 countries, with growing US operations focused on forest and freshwater restoration.

Smithsonian Conservation Biology Institute operates the leading conservation genetics laboratory in the US, providing genomic services to federal agencies, state wildlife departments, and private landowners.

Emerging Startups

NatureMetrics provides eDNA-based biodiversity monitoring as a service, with automated sampling kits and cloud-based analytics that reduce survey costs by 70% compared to traditional methods.

Colossal Biosciences applies CRISPR and computational biology to species recovery, with conservation genetics spinoff technologies applicable to population management and genetic rescue programs.

Terrain (formerly TerraRestore) combines drone technology with genetically optimized seed mixes for large-scale ecosystem restoration, operating across 28 US states.

Key Investors and Funders

Lowercarbon Capital has invested in multiple conservation technology startups, including companies developing eDNA platforms and restoration robotics.

Obvious Ventures backed Colossal Biosciences and maintains an active portfolio in biodiversity technology and nature-based solutions.

USDA Natural Resources Conservation Service administers over $4 billion in conservation and restoration funding through the Inflation Reduction Act, representing the largest public funding source for US biodiversity work.

Action Checklist

• Assess organizational exposure to biodiversity-related regulatory requirements including TNFD reporting and supply chain biodiversity due diligence
• Evaluate eDNA monitoring providers for baseline biodiversity assessments across operational sites and supply chain origins
• Review genetic diversity requirements for any corporate reforestation or habitat restoration commitments
• Investigate biodiversity credit markets for both compliance obligations and voluntary offset opportunities
• Engage conservation genetics consultants to assess genetic viability of any species-specific commitments or habitat restoration programs
• Allocate budget for multi-year biodiversity monitoring programs that include genetic diversity metrics alongside species counts
• Establish relationships with mitigation banks in jurisdictions where operations create biodiversity impacts
• Integrate biodiversity risk metrics into investment due diligence processes alongside existing climate risk assessments

FAQ

Q: How do biodiversity credits differ from carbon credits, and can they be combined? A: Biodiversity credits measure verified gains in species richness, habitat quality, or ecosystem function, while carbon credits measure tonnes of CO2 equivalent reduced or removed. The two are distinct but increasingly "stacked," meaning a single project can generate both carbon and biodiversity credits if it meets the verification requirements for each. However, buyers should be cautious about double-counting: some standards prohibit claiming the same hectare of restoration for both carbon and biodiversity benefits unless additionality is demonstrated independently for each outcome.

Q: What is the current cost range for eDNA biodiversity monitoring compared to traditional surveys? A: eDNA monitoring typically costs $150 to $400 per sample site, with each sample capable of detecting hundreds of species simultaneously. Traditional ecological surveys for comparable species coverage cost $2,000 to $8,000 per site and require multiple visits across seasons. For landscape-scale monitoring programs covering 50 or more sites, eDNA reduces total survey costs by 60 to 80% while providing more comprehensive species detection, particularly for rare, cryptic, or aquatic organisms.

Q: What return profiles are biodiversity investments generating? A: Returns vary dramatically by investment type. US wetland and species mitigation banks generate 15 to 22% returns on invested capital for well-managed operations, driven by regulatory demand. Biodiversity credit markets in voluntary segments currently generate 8 to 14% returns but carry higher market risk due to evolving standards. Conservation genetics service companies are achieving revenue growth of 30 to 50% annually, with the sector attracting venture capital at valuations comparable to climate technology companies. Large-scale restoration contracting operates on thinner margins of 8 to 15% but benefits from long-duration government contracts.

Q: How mature are conservation genetics tools for practical application by non-specialists? A: The accessibility of conservation genetics has improved dramatically since 2023. eDNA sampling kits now require minimal training and can be deployed by field staff without genetics expertise. Bioinformatics analysis is increasingly automated through cloud platforms that convert raw sequence data into standardized biodiversity reports. However, interpreting results for management decisions, such as determining minimum viable population sizes, designing genetic rescue programs, or evaluating translocation candidates, still requires specialist consultation. Organizations should budget for both the technology platform and expert interpretation services.

Sources

• Paulson Institute, The Nature Conservancy, and Cornell Atkinson Center for Sustainability. (2025). Financing Nature: Closing the Global Biodiversity Financing Gap, Third Edition. Paulson Institute.
• Taskforce on Nature-related Financial Disclosures. (2023). Recommendations of the Taskforce on Nature-related Financial Disclosures. TNFD Secretariat.
• MarketsandMarkets. (2025). Environmental DNA (eDNA) Market: Global Forecast to 2027. Pune, India: MarketsandMarkets Research.
• Laikre, L., et al. (2024). "Post-2020 Genetic Diversity Targets in the Convention on Biological Diversity." Science, 383(6685), 893-898.
• Jones, H.P., et al. (2024). "Monitoring Outcomes of Ecosystem Restoration: A Global Meta-Analysis." Nature Ecology & Evolution, 8(2), 234-248.
• US Department of Agriculture. (2025). Inflation Reduction Act Conservation Investments: Progress Report. Washington, DC: USDA.
• CDP Worldwide. (2025). Biodiversity Disclosure Progress Report 2025. London: CDP.